Aviragen Therapeutics (AVIR) Misses Q4 EPS Views

September 14, 2016 4:04 PM EDT
Get Alerts AVIR Hot Sheet
Price: $1.31 -4.38%

Today's EPS Names:
GCO, ALCO, BIG, More
Trade AVIR Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Aviragen Therapeutics (NASDAQ: AVIR) reported Q4 EPS of ($0.18), $0.43 worse than the analyst estimate of $0.25. Revenue for the quarter came in at $60 thousand versus the consensus estimate of $21 million.

For earnings history and earnings-related data on Aviragen Therapeutics (AVIR) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment